Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,917 | 427 | 99.3% |
| Education | $73.44 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,649 | 52 | $0 (2024) |
| Amgen Inc. | $1,504 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,014 | 49 | $0 (2024) |
| ABBVIE INC. | $869.78 | 56 | $0 (2024) |
| Novo Nordisk Inc | $799.43 | 34 | $0 (2024) |
| PFIZER INC. | $655.05 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $530.65 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $429.03 | 7 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $413.33 | 15 | $0 (2024) |
| Lilly USA, LLC | $317.28 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,986 | 98 | AstraZeneca Pharmaceuticals LP ($516.94) |
| 2023 | $1,756 | 79 | AstraZeneca Pharmaceuticals LP ($536.47) |
| 2022 | $1,328 | 65 | ABBVIE INC. ($255.97) |
| 2021 | $788.58 | 47 | Amgen Inc. ($190.60) |
| 2020 | $827.44 | 41 | Amgen Inc. ($232.23) |
| 2019 | $1,172 | 38 | Amgen Inc. ($494.67) |
| 2018 | $947.96 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($189.56) |
| 2017 | $1,184 | 36 | Boehringer Ingelheim Pharmaceuticals, Inc. ($404.29) |
All Payment Transactions
433 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Obesity | ||||||
| 12/03/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.60 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.60 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Insomnia | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $21.07 | General |
| 09/24/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 949 | 1,182 | $170,439 | $80,942 |
| 2022 | 15 | 921 | 1,207 | $145,553 | $63,424 |
| 2021 | 20 | 1,218 | 1,593 | $189,455 | $90,295 |
| 2020 | 13 | 1,142 | 1,669 | $194,519 | $83,622 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 19 | 19 | $10,146 | $3,537 | 34.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 12 | 12 | $3,468 | $1,957 | 56.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $3,984 | $1,263 | 31.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 237 | 371 | $5,565 | $1,103 | 19.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 51 | 53 | $2,544 | $1,033 | 40.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 63 | 65 | $2,655 | $1,006 | 37.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 12 | 12 | $948.00 | $731.76 | 77.2% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 27 | 34 | $2,040 | $416.24 | 20.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 13 | 13 | $527.00 | $200.57 | 38.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 24 | 30 | $480.00 | $66.90 | 13.9% |
About Dr. James Dailey, D.O
Dr. James Dailey, D.O is a Family Medicine healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730120759.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Dailey, D.O has received a total of $9,990 in payments from pharmaceutical and medical device companies, with $1,986 received in 2024. These payments were reported across 433 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($9,917).
As a Medicare-enrolled provider, Dailey has provided services to 4,230 Medicare beneficiaries, totaling 5,651 services with total Medicare billing of $318,284. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Joplin, MO
- Active Since 06/09/2006
- Last Updated 07/23/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730120759
Products in Payments
- JARDIANCE (Drug) $689.88
- FARXIGA (Drug) $673.89
- BREZTRI (Drug) $618.80
- Ozempic (Drug) $530.77
- EVENITY (Biological) $518.52
- VRAYLAR (Drug) $513.08
- Aimovig (Biological) $498.71
- REXULTI (Drug) $433.36
- XARELTO (Drug) $329.34
- TRELEGY ELLIPTA (Drug) $297.86
- ELIQUIS (Drug) $247.75
- Repatha (Biological) $230.45
- FREESTYLE LIBRE (Device) $203.42
- QULIPTA (Drug) $193.44
- PRADAXA (Drug) $180.00
- ENTRESTO (Drug) $173.66
- SHINGRIX (Biological) $168.92
- BELSOMRA (Drug) $164.94
- TRULICITY (Drug) $149.32
- Prolia (Biological) $128.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Joplin
Dr. Luke Wicke, Do, DO
Family Medicine — Payments: $14,984
Dr. Maria Fe Bruce, Md, MD
Family Medicine — Payments: $12,947
Troy D'amour, Do, DO
Family Medicine — Payments: $11,869
Sean Pfeffer, Md, MD
Family Medicine — Payments: $9,746
William Hughes, Do, DO
Family Medicine — Payments: $7,047
Amanda Andrade, Do, DO
Family Medicine — Payments: $6,472